Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.700
-0.220 (-7.53%)
At close: Apr 28, 2026, 4:00 PM EDT
2.720
+0.020 (0.74%)
After-hours: Apr 28, 2026, 7:00 PM EDT

BDTX Statistics

Total Valuation

BDTX has a market cap or net worth of $154.68 million. The enterprise value is $46.53 million.

Market Cap 154.68M
Enterprise Value 46.53M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date May 8, 2026
Ex-Dividend Date n/a

Share Statistics

BDTX has 57.29 million shares outstanding. The number of shares has increased by 4.61% in one year.

Current Share Class 57.29M
Shares Outstanding 57.29M
Shares Change (YoY) +4.61%
Shares Change (QoQ) +0.28%
Owned by Insiders (%) 0.67%
Owned by Institutions (%) 58.51%
Float 46.25M

Valuation Ratios

The trailing PE ratio is 6.92.

PE Ratio 6.92
Forward PE n/a
PS Ratio 2.23
Forward PS n/a
PB Ratio 1.49
P/TBV Ratio 1.39
P/FCF Ratio 5.28
P/OCF Ratio 5.28
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.30, with an EV/FCF ratio of 1.57.

EV / Earnings 2.08
EV / Sales 0.66
EV / EBITDA 2.30
EV / EBIT 2.34
EV / FCF 1.57

Financial Position

The company has a current ratio of 8.42, with a Debt / Equity ratio of 0.17.

Current Ratio 8.42
Quick Ratio 8.18
Debt / Equity 0.17
Debt / EBITDA 0.88
Debt / FCF 0.63
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 22.88% and return on invested capital (ROIC) is 10.50%.

Return on Equity (ROE) 22.88%
Return on Assets (ROA) 9.35%
Return on Invested Capital (ROIC) 10.50%
Return on Capital Employed (ROCE) 15.61%
Weighted Average Cost of Capital (WACC) 20.44%
Revenue Per Employee $3.33M
Profits Per Employee $1.07M
Employee Count 21
Asset Turnover 0.53
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +69.81% in the last 52 weeks. The beta is 3.39, so BDTX's price volatility has been higher than the market average.

Beta (5Y) 3.39
52-Week Price Change +69.81%
50-Day Moving Average 2.45
200-Day Moving Average 2.95
Relative Strength Index (RSI) 49.99
Average Volume (20 Days) 855,992

Short Selling Information

The latest short interest is 5.47 million, so 9.55% of the outstanding shares have been sold short.

Short Interest 5.47M
Short Previous Month 5.07M
Short % of Shares Out 9.55%
Short % of Float 11.84%
Short Ratio (days to cover) 8.50

Income Statement

In the last 12 months, BDTX had revenue of $70.00 million and earned $22.37 million in profits. Earnings per share was $0.39.

Revenue 70.00M
Gross Profit 70.00M
Operating Income 19.87M
Pretax Income 22.37M
Net Income 22.37M
EBITDA 20.20M
EBIT 19.87M
Earnings Per Share (EPS) $0.39
Full Income Statement

Balance Sheet

The company has $128.65 million in cash and $18.78 million in debt, giving a net cash position of $109.87 million or $1.92 per share.

Cash & Cash Equivalents 128.65M
Total Debt 18.78M
Net Cash 109.87M
Net Cash Per Share $1.92
Equity (Book Value) 112.21M
Book Value Per Share 1.96
Working Capital 116.71M
Full Balance Sheet

Cash Flow

Operating Cash Flow 29.61M
Capital Expenditures n/a
Depreciation & Amortization 325,000
Net Borrowing n/a
Free Cash Flow 29.61M
FCF Per Share $0.52
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 28.39% and 31.95%.

Gross Margin 100.00%
Operating Margin 28.39%
Pretax Margin 31.95%
Profit Margin 31.95%
EBITDA Margin 28.85%
EBIT Margin 28.39%
FCF Margin 42.31%

Dividends & Yields

BDTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.61%
Shareholder Yield -4.61%
Earnings Yield 14.30%
FCF Yield 18.93%

Analyst Forecast

The average price target for BDTX is $9.50, which is 251.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.50
Price Target Difference 251.85%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 32.65%
EPS Growth Forecast (5Y) 25.50%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BDTX has an Altman Z-Score of 0.3 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.3
Piotroski F-Score 5